These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3490869)

  • 1. Cuprophan membrane induces interleukin-1 activity.
    Yamagami S; Yoshihara H; Kishimoto T; Sugimura T; Niwa M; Maekawa M
    ASAIO Trans; 1986; 32(1):98-101. PubMed ID: 3490869
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
    Linnenweber S; Lonnemann G
    Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of interleukin 1 receptor antagonist and interleukin 1 during haemodialysis with cellulose membranes.
    Frith SE; Hoenich NA; Redfern CP; Goodship TH
    Int J Artif Organs; 1994 Sep; 17(9):478-87. PubMed ID: 7890436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucocyte occlusion of cuprophane membranes as a cause of reduced hemodialysis efficiency.
    Dodd NJ; Parsons V; Weston MJ
    Int J Artif Organs; 1982 Jul; 5(4):275-6. PubMed ID: 7118290
    [No Abstract]   [Full Text] [Related]  

  • 5. Polyacrilonytrile versus cuprophan membranes for hemodialysis: evaluation of efficacy and biocompatibility by platelet aggregation studies.
    Berrettini M; Buoncristiani U; Parise P; Ballatori E; Nenci GG
    Int J Artif Organs; 1981 Sep; 4(5):218-22. PubMed ID: 7319659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodialysis-induced activation of complement. Effects of different membranes.
    Levett DL; Woffindin C; Bird AG; Hoenich NA; Ward MK; Kerr DN
    Blood Purif; 1986; 4(4):185-93. PubMed ID: 3790264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane].
    Pak K; Kobira S; Tomoyoshi T; Nishimura N
    Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane selection for renal replacement therapy: a mountain or molehill?
    Farrell PC; Odell RA
    Contrib Nephrol; 1985; 44():97-111. PubMed ID: 3886286
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of dialysers with low-flux membranes: significant differences in spite of many similarities.
    Ward RA; Buscaroli A; Schmidt B; Stefoni S; Gurland HJ; Klinkmann H
    Nephrol Dial Transplant; 1997 May; 12(5):965-72. PubMed ID: 9175051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protamine-coated Cuprophan. A potential nonthrombogenic hemodialysis membrane with improved blood compatibility.
    Yang VC; Fu YY; Kim JS
    ASAIO Trans; 1991; 37(3):M229-32. PubMed ID: 1751122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on dialyzers with improved biocompatibility.
    van der Steen A
    Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
    Starzyk J; Bartelik S; Sarnecka S
    Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 16. Limulus amebocyte lysate reactivity, complement activation, and patients' symptoms. Comparison of dialyzer membranes.
    Moss AH; Hamrick RM; Shen SH
    ASAIO Trans; 1989; 35(4):812-5. PubMed ID: 2611049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bag-filter model of a new prêt à porter artificial kidney.
    Bazzato G; Coli U; Landini S; Fracasso A; Morachiello P; Righetto F; Scanferla F
    ASAIO Trans; 1986; 32(1):123-6. PubMed ID: 3778696
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activation of human complement by polyacrilonitrile dialyzer membrane assayed by complement binding to bystander red cells.
    Shastri KA; Logue GL
    ASAIO J; 1992; 38(1):47-51. PubMed ID: 1554917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dialyser membrane material on intradialytic changes in platelet count, platelet aggregation, circulating platelet aggregates and antithrombin III.
    Knudsen F; Nielsen AH; Kristensen SD
    Scand J Urol Nephrol; 1985; 19(3):227-32. PubMed ID: 4070991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S; Kehinde Z; Arije A; Salako BL
    Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.